HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blüher, M. Articles by Paschke, R. Search for Related Content PubMed PubMed Citation Articles by Blüher, M. Articles by Paschke, R. Social Bookmarking                What's this?

Plasma Levels of Tumor Necrosis Factor-, Angiotensin II, Growth Hormone, and IGF-I Are Not Elevated in Insulin-Resistant Obese Individuals With Impaired Glucose Tolerance

From the III Medical Department (M.B., R.P.), Faculty of Medicine, and the Institute of Clinical Chemistry and Pathobiochemistry (J.K.), University of Leipzig, Leipzig, Germany.

Address correspondence and reprint requests to Prof. R. Paschke, University of Leipzig, III. Medical Department, Philipp-Rosenthal-Straße 27, D-04103 Leipzig, Germany. E-mail: pasr{at}medizin3.uni-leipzig.de .

OBJECTIVE— To investigate the relationship between insulin resistance and plasma concentrations of free fatty acids (FFAs), leptin, and potential agonists of the insulin receptor substrate (IRS) system, including tumor necrosis factor- (TNF-), IGF-I, growth hormone (GH), and angiotensin II in individuals with impaired glucose tolerance (IGT).

RESEARCH DESIGN AND METHODS— Because glucose toxicity per se leads to insulin resistance, the determination of the primary metabolic alterations leading to insulin resistance is best accomplished in individuals who are at an increased risk to develop type 2 diabetes. Therefore, 48 subjects with IGT and insulin resistance (IR), characterized by hyperinsulinemic-euglycemic clamps, were compared with 52 healthy insulin-sensitive (IS) control subjects with respect to the relationship between the plasma levels of TNF-, IGF-I, GH, angiotensin II, FFA, leptin, and insulin resistance.

RESULTS— Between the IR and the IS groups, there were no significant differences in the plasma concentrations of TNF-, GH, angiotensin II, IGF-I, and leptin. However, plasma FFA levels were significantly elevated in the IR group compared with the IS group after matching for BMI.

CONCLUSIONS— The plasma concentrations of FFA, but not TNF-, IGF-I, GH, and angiotensin II, are elevated in patients at an early stage of insulin resistance, suggesting that FFAs, but not the other modulators of the IRS system, may be a primary metabolic abnormality leading to insulin resistance.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Bluher, J. W. Bullen Jr., J. H. Lee, S. Kralisch, M. Fasshauer, N. Kloting, J. Niebauer, M. R. Schon, C. J. Williams, and C. S. Mantzoros Circulating Adiponectin and Expression of Adiponectin Receptors in Human Skeletal Muscle: Associations with Metabolic Parameters and Insulin Resistance and Regulation by Physical Training J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2310 - 2316. [Abstract] [Full Text] [PDF]

				R. M. Krauss Lipids and Lipoproteins in Patients With Type 2 Diabetes Diabetes Care, June 1, 2004; 27(6): 1496 - 1504. [Abstract] [Full Text] [PDF]

				T. D. Wiesner, M. Bluher, M. Windgassen, and R. Paschke Improvement of Insulin Sensitivity after Adrenalectomy in Patients with Pheochromocytoma J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3632 - 3636. [Abstract] [Full Text] [PDF]

				J. Krakoff, T. Funahashi, C. D.A. Stehouwer, C. G. Schalkwijk, S. Tanaka, Y. Matsuzawa, S. Kobes, P. A. Tataranni, R. L. Hanson, W. C. Knowler, et al. Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian Diabetes Care, June 1, 2003; 26(6): 1745 - 1751. [Abstract] [Full Text] [PDF]

				P. A. Lee, S. D. Chernausek, A. C. S. Hokken-Koelega, and P. Czernichow International Small for Gestational Age Advisory Board Consensus Development Conference Statement: Management of Short Children Born Small for Gestational Age, April 24-October 1, 2001 Pediatrics, June 1, 2003; 111(6): 1253 - 1261. [Abstract] [Full Text] [PDF]

				S. Dzienis-Straczkowska, M. Straczkowski, M. Szelachowska, A. Stepien, I. Kowalska, and I. Kinalska Soluble Tumor Necrosis Factor-{alpha} Receptors in Young Obese Subjects With Normal and Impaired Glucose Tolerance Diabetes Care, March 1, 2003; 26(3): 875 - 880. [Abstract] [Full Text] [PDF]

				M. Straczkowski, I. Kowalska, A. Stepien, S. Dzienis-Straczkowska, M. Szelachowska, and I. Kinalska Increased Plasma-Soluble Tumor Necrosis Factor-{alpha} Receptor 2 Level in Lean Nondiabetic Offspring of Type 2 Diabetic Subjects Diabetes Care, October 1, 2002; 25(10): 1824 - 1828. [Abstract] [Full Text] [PDF]

				S. Franckhauser, S. Munoz, A. Pujol, A. Casellas, E. Riu, P. Otaegui, B. Su, and F. Bosch Increased Fatty Acid Re-esterification by PEPCK Overexpression in Adipose Tissue Leads to Obesity Without Insulin Resistance Diabetes, March 1, 2002; 51(3): 624 - 630. [Abstract] [Full Text] [PDF]